Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $850.00 | 1 | 49.4% |
| Food and Beverage | $500.77 | 10 | 29.1% |
| Unspecified | $271.55 | 1 | 15.8% |
| Education | $96.81 | 3 | 5.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TOLMAR Pharmaceuticals, Inc. | $850.00 | 1 | $0 (2022) |
| Novo Nordisk Inc | $377.29 | 7 | $0 (2020) |
| Eli Lilly and Company | $271.55 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $139.37 | 2 | $0 (2018) |
| Medtronic, Inc. | $45.69 | 2 | $0 (2024) |
| Abbott Laboratories | $24.17 | 1 | $0 (2018) |
| Arbor Pharmaceuticals, Inc. | $11.06 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.44 | 1 | Medtronic, Inc. ($27.44) |
| 2023 | $18.25 | 1 | Medtronic, Inc. ($18.25) |
| 2022 | $850.00 | 1 | TOLMAR Pharmaceuticals, Inc. ($850.00) |
| 2020 | $32.27 | 1 | Novo Nordisk Inc ($32.27) |
| 2019 | $100.00 | 1 | Novo Nordisk Inc ($100.00) |
| 2018 | $163.54 | 3 | SANOFI-AVENTIS U.S. LLC ($139.37) |
| 2017 | $527.63 | 7 | Eli Lilly and Company ($271.55) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Durable Pump | ||||||
| 09/27/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Durable Pump | ||||||
| 10/06/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 01/28/2020 | Novo Nordisk Inc | Victoza (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 01/24/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 12/19/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Vascular | ||||||
| 04/05/2018 | SANOFI-AVENTIS U.S. LLC | DIABETES - DISEASE (Drug) | Food and Beverage | In-kind items and services | $64.37 | General |
| 01/18/2018 | SANOFI-AVENTIS U.S. LLC | DIABETES - DISEASE (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| 12/04/2017 | Arbor Pharmaceuticals, Inc. | Triptodur (Drug) | Food and Beverage | Cash or cash equivalent | $11.06 | General |
| Category: Pediatrics/Neonatology | ||||||
| 11/09/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $76.20 | General |
| 02/16/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $88.28 | General |
| Category: Diabetes | ||||||
| 02/09/2017 | Novo Nordisk Inc | Tresiba (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 02/09/2017 | Novo Nordisk Inc | Tresiba (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 02/02/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 01/31/2017 | Eli Lilly and Company | TRULICITY (Drug) | — | In-kind items and services | $271.55 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACEBO IN PEDIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS-AWARD-PEDS- ASSESSMENT OF WEEKLY ADMINISTRATION OF LY2189265 IN DIABETES-PEDIATRIC STUDY • Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACEBO IN PEDIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS-AWARD-PEDS- ASSESSMENT OF WEEKLY ADMINISTRATION OF LY2189265 IN DIABETES-PEDIATRIC STUDY | Eli Lilly and Company | $271.55 | 1 |
About Dr. Maya Hunter, MD
Dr. Maya Hunter, MD is a Pediatric Endocrinology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821066416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maya Hunter, MD has received a total of $1,719 in payments from pharmaceutical and medical device companies, with $27.44 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($850.00).
Practice Information
- Specialty Pediatric Endocrinology
- Location Portland, OR
- Active Since 03/09/2006
- Last Updated 04/30/2012
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1821066416
Products in Payments
- FENSOLVI (Drug) $850.00
- TRULICITY (Drug) $271.55
- Tresiba (Drug) $168.82
- DIABETES - DISEASE (Drug) $139.37
- MINIMED 780G (Device) $45.69
- Victoza (Drug) $32.27
- Mitra Clip system (Device) $24.17
- Triptodur (Drug) $11.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Portland
Rushika Conroy, M.d, M.D
Pediatric Endocrinology — Payments: $71,577
Daniel Marks, Md, MD
Pediatric Endocrinology — Payments: $68,472
Bruce Boston, Md, MD
Pediatric Endocrinology — Payments: $24,025
Stephen Lafranchi, Md, MD
Pediatric Endocrinology — Payments: $1,125
Kathryn Woods, Md, MD
Pediatric Endocrinology — Payments: $630.29
Dr. Radhika Purushothaman, Md,Mph, MD,MPH
Pediatric Endocrinology — Payments: $553.45